DiscoverSmart Money CircleThis Biotech CEO Has a Unique Approach To Fight Cancer. Cel-Sci Corp CEO - $CVM
This Biotech CEO Has a Unique Approach To Fight Cancer. Cel-Sci Corp CEO - $CVM

This Biotech CEO Has a Unique Approach To Fight Cancer. Cel-Sci Corp CEO - $CVM

Update: 2024-10-21
Share

Description

This Biotech CEO Has a Unique Approach To Fight Cancer. Cel-Sci Corp CEO - $CVM




Guest: Geert Kersten CEO of CEL SCI Corp $CVM


Ticker: $CVM


Website: https://cel-sci.com/




Geert Kersten Biography


Geert Kersten has served in his current leadership role as Chief Executive Officer at CEL-SCI Corporation (NYSE American: CVM) since 1995 and has been with CEL-SCI since 1987. He has been involved in the pioneering field of cancer immunotherapy for over three decades and has successfully steered CEL-SCI through many challenging cycles in the biotechnology industry. Mr. Kersten also provides CEL-SCI with significant expertise in the fields of finance and law and has a unique vision of how CEL-SCI's Multikine product could potentially change the way cancer is treated. Prior to joining CEL-SCI, Mr. Kersten worked at the law firm of Finley & Kumble and worked at Source Capital. Mr. Kersten received his Undergraduate Degree in Accounting and an M.B.A. from George Washington University, and a law degree (J.D.) from American University in Washington, DC.




Investors Can Learn More:


https://cel-sci.com/new-investor-information/



---

Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

This Biotech CEO Has a Unique Approach To Fight Cancer. Cel-Sci Corp CEO - $CVM

This Biotech CEO Has a Unique Approach To Fight Cancer. Cel-Sci Corp CEO - $CVM

Adam Sarhan